Safety of TEG001 in patients with r/r AML, high-risk MDS or MM

Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2017
This article has no abstract
Epistemonikos ID: cab62179c5746c834f33e5c3ffe10fcb5d939586
First added on: Apr 16, 2025